92.17
-3.37 (-3.53%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Blueprint Medicines Corporation | Bullish | Bullish |
Stockmoo Score
|
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 138.00 (Guggenheim, 49.72%) | Buy |
| Median | 125.00 (35.62%) | |
| Low | 105.00 (Barclays, 13.92%) | Hold |
| Average | 123.57 (34.07%) | |
| Total | 5 Buy, 2 Hold | |
| Avg. Price @ Call | 105.93 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 02 Aug 2024 | 127.00 (37.79%) | Buy | 96.72 |
| Guggenheim | 02 Aug 2024 | 138.00 (49.72%) | Buy | 96.72 |
| Needham | 01 Aug 2024 | 130.00 (41.04%) | Buy | 100.29 |
| 28 Jun 2024 | 130.00 (41.04%) | Buy | 107.78 | |
| Barclays | 29 Jul 2024 | 105.00 (13.92%) | Hold | 110.34 |
| Morgan Stanley | 12 Jul 2024 | 115.00 (24.77%) | Hold | 117.78 |
| Oppenheimer | 08 Jul 2024 | 125.00 (35.62%) | Buy | 116.32 |
| JMP Securities | 07 Jun 2024 | 125.00 (35.62%) | Buy | 103.34 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 01 Aug 2024 | Announcement | Blueprint Medicines Reports Second Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance |
| 18 Jul 2024 | Announcement | Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |